Governance Zealand Pharma A/S

ZEAL

DK0060257814

Biotechnology & Medical Research

Real-time Estimate Cboe Europe Other stock markets 09:02:49 2026-06-11 am EDT			5-day change	1st Jan Change
284.25 ^DKK	+0.30%		-12.81%	-39.00%

Jun. 10	Lilly stays ahead of the pack as rivals jump on obesity drug bandwagon	RE
Jun. 10	DNB Carnegie trims Zealand Pharma price target to DKK 425 (440), reiterates Buy	FW

Executive Committee: Zealand Pharma A/S

Manager

Positions heldSince

Adam Sinding Steensberg

52 year

Chief Executive Officer	2022-03-29
President	2022-03-29

Neshat Anis Ahmadi

Investor Relations Contact

2024-09-30

Utpal Singh

Chief Tech/Sci/R&D Officer

2025-04-22

Henriette Wennicke

Director of Finance/CFO

2022-10-31

David Kendall

64 year

Chief Tech/Sci/R&D Officer

2022-06-01

Christina Sonnenborg Bredal

41 year

Human Resources Officer

2019-12-31

Ivan Møller

54 year

Chief Operating Officer

2018-02-28

Composition of the Board of Directors: Zealand Pharma A/S

Director

CommitteesSince

Alf Gunnar Martin Nicklasson

71 year

Audit Committee	2017-04-04
Compensation Committee	2016-04-20
Nominating Committee
Compensation Committee Chair	2014-12-31

Leonard Kruimer

68 year

Audit Committee	2018-04-23
Compensation Committee	2021-12-31
Nominating Committee	2019-04-03
Audit Committee Chair	2021-12-31

Elaine Sullivan

65 year

Audit Committee	2025-06-10
Compensation Committee Chair

Kirsten Drejer

69 year

Nominating Committee Chair

2018-04-18

Enrique Conterno

59 year

Compensation Committee

Iris Löw-Friedrich

Compensation Committee

2026-03-25

Camilla Sylvest

54 year

Director/Board Member

2026-05-25

Frederik Barfoed Beck

59 year

Director/Board Member

2019-12-31

Anneline Nansen

57 year

Director/Board Member

2021-08-31

Ludovic Otterbein

53 year

Director/Board Member

2024-03-19

Adam Nygaard

Director/Board Member

2024-03-19

Latest Appointments: Zealand Pharma A/S

May. 26	Zealand Pharma A/S Elects Camilla Sylvest to the Board of Directors	CI
Apr. 14	Zealand Pharma A/S Announces the Appointment of Eric Rojas as Head of Investor Relations, Effective April 15, 2026	CI
Mar. 26	Zealand Pharma A/S Approves Management Changes	CI
Mar. 10	Spago Nanomedical AB Appoints Torsten Malmström as Director CMC & Supply and Management Team Member	CI
Feb. 24	N4 Pharma Names Zealand Pharma CEO to Same Role	MT
Feb. 24	N4 Pharma plc Announces CEO Changes	CI
25-10-21	Novo Nordisk's top investor seizes board control in weight-loss drug battle	RE

More news

Former Officers and Directors: Zealand Pharma A/S

Insider

Positions held

SinceUntil

Bernadette Connaughton

Director/Board Member	2019-04-03	2026-03-25
Independent Dir/Board Member	2019-04-03	2026-03-25

Jeffrey Berkowitz

Director/Board Member	2019-04-03	2026-03-25
Independent Dir/Board Member	2019-04-03	2026-03-25

Jens Stenvang

Director/Board Member

2013-12-31

2024-03-19

Iben Louise Gjelstrup

Director/Board Member

2019-12-31

2024-03-19

Michael Owen

Director/Board Member	2012-04-24	2024-03-19
Independent Dir/Board Member	2012-04-24	2024-03-19

Matthew D. Dallas

Director of Finance/CFO	2019-10-06	2022-08-30
Investor Relations Contact	2019-10-06	2022-08-30

Rie Schultz Hansen

Chief Tech/Sci/R&D Officer	2019-07-28	-
Corporate Officer/Principal	-	2022-07-31

Emmanuel Dulac

Chief Executive Officer	2019-04-21	2022-03-29
President	2019-04-21	2022-03-29

Marino Garcia

Corporate Officer/Principal

2018-09-30

2021-09-30

Gertrud Koefoed Rasmussen

Director/Board Member

2019-12-31

2021-08-30

Mads Vindahl Kronborg

Investor Relations Contact	2020-08-02	-
Public Communications Contact	2020-08-02	-

Lani Pollworth Morvan

Investor Relations Contact	2018-07-31	2020-06-30
Public Communications Contact	2018-07-31	2020-06-30

Andrew Parker

Chief Tech/Sci/R&D Officer

2016-06-30

2019-08-30

Rosemary Crane

Director/Board Member	2015-08-31	2019-04-03
Independent Dir/Board Member	2015-08-31	2019-04-03

Catherine Moukheibir

Director/Board Member	2014-08-31	2019-04-03
Independent Dir/Board Member	2014-08-31	2019-04-03

Mats Blom

Director of Finance/CFO	2010-03-21	2019-03-30
Investor Relations Contact	2010-02-28	-

Britt Meelby Jensen

Chief Executive Officer	2015-01-14	2019-02-27
President	-	2019-02-27

Helle Haxgart

Director/Board Member

2016-12-31

2018-04-18

Kirsten Dreyer

Director/Board Member

2018-04-18

Eva Steiness

Chief Executive Officer	1997-12-31	2017-10-31
Founder	2006-12-31	2017-10-31

Rasmus Just

Director/Board Member	2016-04-18	2016-12-31
Corporate Officer/Principal	2015-12-31	2016-12-31

Helle Størum

Director/Board Member	2007-12-31	2016-04-18
Corporate Officer/Principal	2011-01-27	2016-12-31

Hanne Leth Hillman

Investor Relations Contact	2010-12-31	2016-09-30
Public Communications Contact	2010-12-31	2016-09-30

Carlos de Sousa

Corporate Officer/Principal

2015-11-30

David Solomon

Chief Executive Officer	2008-10-31	2015-01-14
President	2009-10-20	2015-01-14

Torsten Hoffmann

Chief Tech/Sci/R&D Officer

2013-06-30

2014-12-31

John Hyttel

Chief Operating Officer	2012-02-07	2013-01-31
Founder	2013-01-14	2013-01-31
General Counsel	1998-10-18	2012-02-07

Agneta Svedberg

Chief Operating Officer

2013-01-31

Jørgen Lindegaard

Director/Board Member	2011-04-27	-
Independent Dir/Board Member	2011-04-27	-

Jutta Grevinde af Rosenborg

Director/Board Member	2011-04-27	-
Independent Dir/Board Member	2011-04-27	-

Christian Gröndahl

Chief Tech/Sci/R&D Officer

2010-04-05

Thomas Tscherning

Director/Board Member

2007-12-31

2009-12-31

Florian Reinaud

Director/Board Member	2010-08-29	-
Independent Dir/Board Member	2012-03-14	-

Mogens Vang Rasmussen

Chief Operating Officer	2009-10-20	2009-12-31
Chief Tech/Sci/R&D Officer	2009-10-20	2009-12-31
Director of Finance/CFO	2002-12-31	2009-12-31
Public Communications Contact	2002-12-31	2009-12-31

Anders Fink Vadsholt

Director/Board Member

2009-10-20

2009-12-31

Jean Christophe Renondin

Director/Board Member

2005-12-31

2008-12-31

Arvind M. Hundal

Corporate Officer/Principal

2011-09-01

Christian Herskind Jørgensen

Director/Board Member

2007-12-31

Jesper Zeuthen

Chairman

2006-12-31

Peter James Arthur Benson

Director/Board Member	2006-12-31	-
Independent Dir/Board Member	2006-12-31	-

Linda Sjöström

Director/Board Member

2006-12-31

Jens W. Kindtler

Director/Board Member

2006-12-31

Alain Munoz

Director/Board Member	2004-12-31	2005-12-31
Director/Board Member	2006-12-31	2024-03-19
Independent Dir/Board Member	2006-12-31	2024-03-19

Marlene Nørgaard

Director/Board Member

2005-12-31

Rémi Droller

Director/Board Member

2005-12-31

Hanne Heidenheim Bak

Director/Board Member

2012-04-24

Jürgen Langhärig

Corporate Officer/Principal

2005-10-31

Christian Thorkildsen

Director/Board Member	2004-12-31	2016-04-18
Corporate Officer/Principal	2004-12-31	-

Daniël Jan Ellens

Chairman	2004-12-31	-
Independent Dir/Board Member	2004-12-31	-

Lone Skjøttgaard Due

Director/Board Member

2003-12-31

Jan Honoré

Chairman

2003-12-31

Bo Lennart Bruce

Director/Board Member

2002-12-31

Leif Helth Jensen

Founder

1998-10-18

Lars Kolind

Director/Board Member

1997-12-31

Bjarne Due Larsen

Founder

1997-03-31

Lars Christiansen

Founder

1997-03-31

Linda Basse

Chief Tech/Sci/R&D Officer

Jakob Dynnes Hansen

Director of Finance/CFO

Peter Andersen

Founder

Peter Damsbo

Chief Tech/Sci/R&D Officer

Florian Schönharting

Founder

Alette Pramming

Public Communications Contact

Steven Glazer

Corporate Officer/Principal

Torsten Malmström

Corporate Officer/Principal

René Kuijten

Director/Board Member

Henrik Landwehr

Human Resources Officer

Kenneth William Harlow

Corporate Officer/Principal

Christine Andersen

Corporate Officer/Principal

2012-04-24

Jørgen Buus Lassen

Chairman

2010-08-10

Christina Guldberg

Corporate Officer/Principal

Jens D. Mikkelsen

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	14
Female	7

Of which Executive Committee

Male	4
Female	3

Of which Directors

Male	8
Female	3

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Zealand Pharma A/S is specialized in the research and development of peptide drugs mainly for the treatment of diabetes, rare diseases and obesity. At the end of 2025, the Group had a portfolio of 8 products in clinical development (including 3 in phase III, 3 in phase II and 2 in phase I), and 1 product in preclinical development.

Employees

544

Sector

Biotechnology & Medical Research

Calendar

Earnings release - Q2 2026

More about the company